Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin

Cancer Letters

Volumn 256, Issue 1, 2007, Pages 29-32

  Li, Xiaokun ^a,b,c   Jiang, Lijuan ^a   Wang, Yi ^a   Xiao, Yechen ^c   Huang, Yadong ^b   Yao, Qiongfeng ^b   Yang, Yongguang ^a,d   Wu, Xiaoping ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Cancer; Peptide; Platelet factor 4; Vasostatin

Indexed keywords

ANGIOGENESIS INHIBITOR; GLYCINE DERIVATIVE; GLYCYLPROLYLGLYCINE; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; VASOSTATIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; ANIMALS; CALRETICULIN; CELL PROLIFERATION; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLATELET FACTOR 4; RECOMBINANT FUSION PROTEINS;

EID: 34548293624     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.05.002     Document Type: Article

References (12)

1. Hanahan D., and Folkman J. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis. Cell 86 (1996) 353-364
2. Boehm T., Folkman J., Browder T., and O'reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390 (1997) 404-407
3. Gupta G.P., and Massague J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
4. Scappaticci F.A., Smith R., Pathak A., Schloss D., Lum B., Cao Y., Johnson F., Engleman E.G., and Nolan G.P. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. Molecular Therapy 3 (2001) 186-196
5. Yao L., Pike S.E., Setsuda J., Parekh J., Gupta G., Raffeld M., Jaffe E.S., and Tosato G. Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. Blood 96 (2000) 1900-1905
6. Pike S.E., Yao L., Jones K.D., Cherney B., Appella E., Sakaguchi K., Nakhasi H., Teruya-Feldstein J., Wirth P., Gupta G., and Tosato G. Vasostatin, a calreticulin fragment inhibits angiogenesis and suppresses tumor growth. J. Exp. Med. 188 (1998) 2349-2356
7. Pike S.E., Yao L., Setsuda J., Jones K.D., Cherney B., Appella E., Sakaguchi K., Nakhasi H., Atreya C.D., Teruya-Feldstein J., Wirth P., Gupta G., and Tosato G. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 94 (1999) 2461-2468
8. Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., Carson H.F., and Sharpe R.J. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247 (1990) 77-79
9. Liu T.C., Zhang T., Fukuhara H., Kuroda T., Todo T., Martuza R.L., Rabkin S.D., and Kurtz A. Oncolytic HSV armed with platelet factor 4 an antiangiogenic agent shows enhanced efficacy. Molecular Therapy 14 (2006) 789-797
10. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. second ed. (1989), Cold Spring Harbor Laboratory Press, New York
11. Folkman J., Weisz P.B., Joullie M.M., Li W.W., and Ewing W.R. Control of angiogenesis with synthetic heparin substitutes. Science 243 (1989) 1490-1493
12. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., Dzuiba J., Van Damme J., Walz A., Marriott D., Chan S.Y., Roczniak S., and Shanafelt A.B. The functional role of the ELR Motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270 (1995) 27348-27357